drugset / Trial / NCT04304807

Effect of Melatonin on Feeding Intolerance and Incidence of Necrotizing Enterocolitis in Preterm Infants

NCT04304807

Phase 4 Completed 90 enrolled Ain Shams University
RandomizedParallel-groupOpen-labelTreatment

Summary

Assesses the efficacy of melatonin in treatment of feeding intolerance in preterm infants, the time needed to reach full enteral intake, the incidence of necrotizing enterocolitis and measures the level of tumor necrosis factor-alpha as a marker of oxidative stress.

Timeline

Start
2018-12-24
Primary completion
2019-12-20
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 20 mg Other